Breast Cancer

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients

Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy

PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

MammoVerse: Clinicians Focus Group

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer

Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast Cancers

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Tridimensional Geometric Modeling of the Breast

Percutaneous Biopsy After Neoadjuvant Chemotherapy.

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

MammoVerse: Breast Cancer Sexual Health Focus Groups

A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer

Breast Cancer, Reasoning, and Activity Intervention